BIOTECH Logo

BIOTECH

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Biat Group is a biotechnology corporate group that operates through its holding company, Bionatur, and a global commercial network. The group is composed of several subsidiaries with distinct specializations. Biobide is a leading provider of preclinical research, offering toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions leverages a proprietary set of inteins for high-value applications in gene therapy, immunotherapy, in-vitro diagnostics (IVD), smart vaccines, and protein purification. The Bionatur division holds unique biotech assets for human and animal health. The group seeks collaborations in licensing, preclinical research, and vaccine improvement.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for BIOTECH. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-19 14:18
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-18 10:30
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-17 14:38
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-14 10:53
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-13 15:33
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-12 14:50
Net Asset Value
Net Asset Value(s)
English 4.1 KB
2025-03-11 15:54
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-10 14:35
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-07 14:28
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-07 09:08
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-06 15:30
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-06 08:00
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-05 14:34
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-04 14:40
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-03 15:43
Net Asset Value
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Spago Nanomedical AB Logo
Develops nanomedicine for precision MRI tumor diagnostics and targeted cancer radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Developing first-in-class macrocyclic drugs for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops and out-licenses preclinical cancer drug programs using fragment-based discovery.
Sweden SPRINT
Stayble Therapeutics AB Logo
Develops an injectable therapy for disc-related spinal disorders as an alternative to surgery.
Sweden STABL
Stem Cells Spin Spolka Akcyjna Logo
Commercializes patented MIC-1 stem cell technology for regenerative medicine.
Poland SCS
STRIX GROUP PLC Logo Isle of Man KETL
SynAct Pharma Logo
Developing oral resolution therapies for inflammatory diseases like rheumatoid arthritis.
Sweden SYNACT
SYNAIRGEN PLC Logo
Develops an inhaled interferon beta therapy for severe viral lung infections.
United Kingdom SNG
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT
Israel TMIS